What does CUSIP 97382D303 represent in this 13F holders report?

CUSIP 97382D303 is the security identifier for WINT - WINDTREE THERAPEUTICS INC - COM used to aggregate holder disclosures.

How many institutions held WINT - WINDTREE THERAPEUTICS INC - COM in Q1 2021?

14 institutional investors reported WINT - WINDTREE THERAPEUTICS INC - COM for Q1 2021. Use the holders table for investor-level position and value details.

WINDTREE THERAPEUTICS INC - COM (WINT)

CUSIP: 97382D303

Q1 2021 13F Holders as of 31 Mar 2021

Security type / class: Equity / COM
Total 13F shares: 1,109,251
Total 13F value: $2,715,298
Share change: +336,469
SEC-reported price per share: $2.45
Number of holders: 14
Value change: +$440,308
Number of buys: 10
Number of sells: 6

Security key

97382D303

Report period

Q1 2021

Institutions

Top holders

WINT full security history Ownership snapshot Full 13F holder table WINDTREE THERAPEUTICS INC /DE/ SEC filings WINDTREE THERAPEUTICS INC /DE/ company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of WINT - WINDTREE THERAPEUTICS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Center Laboratories, Inc.

Disclosed value leader

Center Laboratories, Inc.

Comparable rows

0/12

Latest evidence

31 Dec 2020

3/4/5 13F Highest disclosed value: $2,527,492 12 rows are not safely comparable across share classes. Showing 1-6 of 12 holder rows.

Quick read

Center Laboratories, Inc. has the largest disclosed position value at $2.53M.

0 of 12 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Center Laboratories, Inc.'s linked filing trail.

Disclosed position value Top 5

Center Laboratories, Inc. $2.53M

VANGUARD GROUP INC $1.42M

MILLENNIUM MANAGEMENT LLC $552K

Kepos Capital LP $462K

NORTHERN TRUST CORP $371K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 12 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Center Laboratories, Inc.	3/4/5 10%+ Owner 3/4/5	— mixed-class rows	$2,527,492 2,782,352 shares mixed-class rows	—	20 May 2020
Bioengine Capital Inc.	3/4/5 10%+ Owner 3/4/5	— mixed-class rows	— 304,176 shares mixed-class rows	—	20 May 2020
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$1,419,000 276,529 shares	—	31 Dec 2020
MILLENNIUM MANAGEMENT LLC	13F Company 13F	— denominator unverified	$552,000 107,505 shares	—	31 Dec 2020
Kepos Capital LP	13F Company 13F	— denominator unverified	$462,000 90,000 shares	—	31 Dec 2020
NORTHERN TRUST CORP	13F Company 13F	— denominator unverified	$371,000 72,385 shares	—	31 Dec 2020

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

1,109,251

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2021 vs Q1 2021 Across Filers

Q1 2021 holders

Holder diff

Investor	Q1 2021 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q1 2021 value	Q1 2021 value	Value change	Value Chg %